UAE becomes second country to approve gene therapy itvisma for spinal muscular atrophy | World News – The Times of India
The UAE approved Itvisma gene therapy for SMA, improving motor function and reducing long-term treatments/Image: WAM The UAE has taken a major step in healthcare innovation by approving Itvisma (onasemnogene abeparvovec), a gene therapy for spinal muscular atrophy (SMA) in adults and children aged two years and above. This makes the country only the second […]
Continue Reading